Ch4: Apply Your Skills: Ethical Dilemma

AH Biotech
AH Biotech

What would you do?

1. Do the clinical trials in Albania. You’ll be able to bring the drug to market faster and cheaper, which will be good for AH Biotech’s employees and investors and good for the millions of people who suffer from anxiety attacks.

I don’t agree with this option because even it is good for AH biotech Company, but for those how are in Albania suffering from anxiety attacks will stop there free treatment and cannot afford after marketing the Drug and it will be difficult for them to buy it as they are poor people.

2. Do the clinical trials in the United States. Even though it will certainly be more expensive and time-consuming, you’ll feel as if you’re living up to the part of the Hippocratic Oath that instructed you to “prescribe regimens for the good of my patients according to my ability and my judgment and never do harm to anyone.”

In my view this is the best option for hassan, even though it is expensive to conduct the tests in the US, because the based clinical studies are far more stronger and in turn will give the company higher returns in the future, also the patients in the US can afford the treatment after the initial free doses are given by the investigators because of the insurance system in place.

3. Do the clinical trials in Albania, and if the drug is approved, use part of the profits to set up a compassionate use program in Albania, even though setting up a distribution system and training doctors to administer the drug, monitor patients for adverse effects, and track results will entail considerable expense.

All these assumptions will take place in future, we don’t know is this drug will be approved or not also we don’t know is it will make a profit or not, that is why we have to think about the Albania’s